Text Size
42 studies found for:    Open Studies | "Cytomegalovirus Infections"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age
Condition: Cytomegalovirus Infections, Heart Transplantation
Intervention: Drug: valganciclovir [Valcyte]
22 Recruiting Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
Conditions: Infections, Cytomegalovirus;   Transmission of Cytomegalovirus Infection From Pregnant Woman to Foetus
Interventions: Procedure: Blood sample;   Procedure: Cord blood sample;   Procedure: Saliva swab;   Procedure: Urine sampling;   Procedure: Vaginal swab
23 Recruiting Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Condition: Cytomegalovirus Congenital Infection
Intervention: Biological: standard intravenous immunoglobulin
24 Recruiting Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
Conditions: Cytomegalovirus Infection;   Renal Transplant Failure;   Transplant; Complication, Rejection
Interventions: Drug: Thymoglobulin;   Drug: Everolimus;   Drug: Basiliximabe;   Drug: mycophenolate sodium;   Drug: Tacrolimus
25 Recruiting Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study
Condition: Cytomegalovirus Infection
Interventions: Biological: Adoptive Cellular Therapy;   Drug: Best available antiviral drug therapy
26 Recruiting Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
Conditions: Sensorineural Hearing Loss;   Cytomegalovirus Infection
Intervention:
27 Recruiting Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: Dose Escalation Comparison
28 Recruiting Alternate Donor Study of Pre-Emptive Cellular Therapy
Condition: Cytomegalovirus Infection
Intervention: Biological: CMV-specific T-cells, single infusion following single positive CMV PCR result
29 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
30 Not yet recruiting Investigation of Six Weeks of Oral Valganciclovir Therapy in Infants and Children With Congenital Cytomegalovirus Infection and Hearing Loss
Conditions: Congenital Cytomegalovirus;   Hearing Loss
Interventions: Drug: Valganciclovir;   Drug: Placebo
31 Recruiting Cut Off for the Diagnosis of Cytomegalovirus (CMV) Disease in Serum-positive Kidney Transplant Recipients
Condition: Cytomegalovirus Disease
Intervention:
32 Not yet recruiting CMV Modulation of the Immune System in ANCA-associated Vasculitis
Conditions: ANCA Associated Vasculitis;   CMV Infection
Intervention: Drug: Valaciclovir
33 Recruiting Study to Explore CMV Infection in Adolescent Girls
Condition: Cytomegalovirus Vaccines
Interventions: Procedure: Blood collection;   Procedure: Urine collection;   Procedure: Dry urine collection;   Procedure: Saliva collection;   Procedure: Urine and/ or saliva collection from newborn in case of pregnancy
34 Recruiting Primary Transplant or Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Condition: Cytomegalovirus
Intervention: Genetic: CMV-pp65 CTLs
35 Recruiting T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease;   Nonneoplastic Condition
Interventions: Biological: adoptive immunotherapy;   Biological: alemtuzumab;   Biological: in vitro-treated peripheral blood lymphocyte therapy;   Drug: foscarnet sodium;   Drug: ganciclovir;   Genetic: polymerase chain reaction;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: infection prophylaxis and management;   Procedure: peripheral blood stem cell transplantation;   Procedure: standard follow-up care;   Radiation: radiation therapy
36 Unknown † Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
Condition: Cytomegalovirus
Interventions: Drug: ganciclovir treatment or monitoring of viral load.;   Other: Monitor or treat with ganciclovir
37 Unknown † Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection
Condition: Neoplasms
Intervention: Other: Immune profiling and DC vaccine
38 Recruiting Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress
Conditions: Cytomegalovirus Viraemia;   Stress, Physiological;   Receptor, Hormonal; Disorder;   Other Deficiency of Cell-mediated Immunity
Intervention:
39 Unknown † Longitudinal Study of Ocular Complications of AIDS (LSOCA)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Cytomegalovirus Retinitis
Intervention: Drug: Highly Active Anti-Retroviral Therapy (HAART)
40 Not yet recruiting The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
Condition: Maternal-fetal Transmission of Cytomegalovirus During Pregnancy
Intervention:
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results
† Indicates status has not been verified in more than two years